ArticleFrontiers in cell and developmental biology2025

Identification of the key immune gene NR3C1 as a diagnostic biomarker in differentiating ovarian borderline tumors from benign tumors.

Shiying Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.